Frontlight ResearchEarly access
Colorectal cancer trials in China
616 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Early phase 1Taking peopleEfficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 14
- Run by
- JIANG LONGWEI
See details and how to joinNCT07343791 - Phase 2Not yet taking people in China125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer
- Where
- Jinan
- Age
- 18 years and over
- People
- 90
- Run by
- Li Min
See details and how to joinNCT07333651 - Phase 2Not yet taking people in ChinaA Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation
- Where
- Harbin
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Yanqiao Zhang
See details and how to joinNCT07229846 - Phase 2Taking peopleNode-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer
- Where
- Hangzhou
- Age
- 18 years to 80 years
- People
- 52
- Run by
- Sir Run Run Shaw Hospital
See details and how to joinNCT07068763 - No phaseTaking peopleTarget-specific immunoPET Imaging of Digestive System Carcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 400
- Run by
- RenJi Hospital
See details and how to joinNCT06715839 - No phaseTaking peopleComprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 300
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07154173 - Phase 3Taking peopleNALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 144
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07309289 - Phase 2Taking peopleNode-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 38
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07279077 - Phase 3Taking peoplemFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 166
- Run by
- Jun Huang
See details and how to joinNCT06791512 - Phase 2Not yet taking people in ChinaPreventive Efficacy of Bergmann Enema for Acute Radiation-induced Rectal Injury in Rectal Cancer Patients Undergoing Short-course Radiotherapy
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07302126 - Phase 2Taking peopleClinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 100
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06540326 - Phase 2Not yet taking people in ChinaSIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 37
- Run by
- Sun Yat-sen University
See details and how to joinNCT07297030 - No phaseTaking peopleComparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 256
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT05943444 - Phase 3Taking peopleA Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 363
- Run by
- Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT06686576 - Phase 2Taking peopleCetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer
- Where
- Foshan, Guangzhou, Guiyang
- Age
- 18 years and over
- People
- 198
- Run by
- Sun Yat-sen University
See details and how to joinNCT05959356 - No phaseTaking peopleUsing ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 497
- Run by
- Fudan University
See details and how to joinNCT07283575 - Phase 2Taking peopleSCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC
- Where
- Jinan
- Age
- 18 years to 80 years
- People
- 208
- Run by
- Shandong Provincial Hospital
See details and how to joinNCT07284992 - Phase 3Taking peopleMegestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRC
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06998758 - No phaseTaking peopleClinical Study of Acupoint Application on Relieving qi Deficiency and Constipation in Patients Undergoing Chemotherapy
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 106
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07276932 - No phaseTaking peopleHealth Behavior Change in High-Risk Colorectal Cancer Individuals
- Where
- Shenyang
- Age
- 18 months to 80 months
- People
- 80
- Run by
- China Medical University, China
See details and how to joinNCT07262840 - No phaseTaking peopleEffect of OFA, OSA Versus Opioid-based Anesthesia on NETs and Cancer Cell Malignancy After Colorectal Cancer Surgery
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 90
- Run by
- Fudan University
See details and how to joinNCT07264556 - Phase 1/2Taking peopleStudy of GV20-0251 in Participants With Solid Tumor Malignancies
- Where
- Beijing, Shanghai
- Age
- 18 years and over
- People
- 350
- Run by
- GV20 Therapeutics
See details and how to joinNCT07070518 - No phaseTaking peopleResponse-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy
- Where
- Chengdu
- Age
- 18 years to 80 years
- People
- 60
- Run by
- West China Hospital
See details and how to joinNCT07260526 - Phase 2Not yet taking people in ChinaTrifluridine/Tipiracil Plus Fruquintinib vs. Trifluridine/Tipiracil Plus Bevacizumab in Refractory Metastatic Colorectal Cancer: A Randomized, Controlled, Open-Label, Non-Inferiority Trial
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 236
- Run by
- Sun Yat-sen University
See details and how to joinNCT07261709 - Phase 2Taking peopleThe Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer
- Where
- Hangzhou
- Age
- 10 years to 85 years
- People
- 70
- Run by
- Zhejiang University
See details and how to joinNCT07257653